Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

DSpace Repository

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

Author: Otieno, Lucas; Mendoza, Yolanda Guerra; Adjei, Samuel; Agbenyega, Tsiri; Agnandji, Selidji Todagbe; Aide, Pedro; Akoo, Pauline; Ansong, Daniel; Asante, Kwaku Poku; Berkley, James A.; Gesase, Samwel; Hamel, Mary J.; Hoffman, Irving; Kaali, Seyram; Kamthunzi, Portia; Kariuki, Simon; Kremsner, Peter; Lanaspa, Miguel; Lell, Bertrand; Lievens, Marc; Lusingu, John; Malabeja, Anangisye; Masoud, Nahya Salim; Mtoro, Ali Takadir; Njuguna, Patricia; Ofori-Anyinam, Opokua; Otieno, Godfrey Allan; Otieno, Walter; Owusu-Agyei, Seth; Schuerman, Lode; Sorgho, Hermann; Tanner, Marcel; Tinto, Halidou; Valea, Innocent; Vandoolaeghe, Pascale; Sacarlal, Jahit; Oneko, Martina
Tübinger Autor(en):
Agnandji, Selidji Todagbe
Kremsner, Peter
Lell, Bertrand
Published in: Vaccine (2020), Bd. 38, H. 4, S. 897-906
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.vaccine.2019.10.077
ISSN: 1873-2518
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)